Impact Evaluation of the Therapeutic Initiative's Uncomplicated Acute Cystitis Personalized Portrait and Therapeutics Letter
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,073
- 试验地点
- 2
- 主要终点
- Monthly prescribing of Nitrofurantoin
研究概览
简要总结
The goal of this randomized trial is to test the impact of mailing personalized prescribing Portraits (an audit and feedback tool) and Therapeutics Letters (a reference document) to physicians on first-line prescribing to patients with uncomplicated urinary tract infection (UTI) .
The main question this study aims to answer is:
• To what extent can personal prescribing feedback Portraits and Therapeutics Letters have an effect on how physicians prescribe antibiotics for uncomplicated UTI?
Approximately 5,000 British Columbian Family Practitioners (FP's) have been randomly divided into three groups, and each group received the Portrait at different times. To help ascertain the possible impact of Portraits, pooled data on first-line prescribing for uncomplicated UTI by FP's who received the Portrait at an early time point (September 23, 2021) will be compared to that of those who received a Portrait at a delayed time point (March 28, 2022). Researchers will compare prescribing data from these groups to see if the prescribing Portraits have had a differential impact on prescribing of antibiotics for uncomplicated UTI.
详细描述
This study is a randomized trial testing the effectiveness of personalized prescribing Portraits and Therapeutics Letters on appropriate treatment for uncomplicated acute cystitis (urinary tract infection) in the primary care setting in the province of British Columbia (B.C.) between September, 2021 and March, 2022.
Approximately 5,000 B.C. physicians were randomly divided into 3 arms (each representing ~ 33%) that received the Portrait and Therapeutics Letter at different times. Approximately 1,691 physicians were randomized to each group. This "designed delay" will enable evaluation of the impact of Portraits and Therapeutics Letters on prescribing at an aggregate level across the province of British Columbia.
On the initial mailing (September 23, 2021), Early Letter + Portrait Arm received a early Portrait (P) + Letter (L), Delayed Control Arm received nothing, and Early Letter Arm received an Early Letter Only. On the delayed mailing (March 28, 2022), both Early Letter Arm and Delayed Control Arm received a delayed Portrait (P) + Letter (L).
Within the study and across these groups, there will be four comparisons as follows:
During the study period (Sept 23, 2021 to Mar 28, 2022):
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Sequential
- 主要目的
- Health Services Research
- 盲法
- Single (Participant)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Physicians who are:
- •i. Registered with the College of Physicians and Surgeons of B.C. (CPSBC) ii. Defined as a General Practitioner or Family Practice - Emergency Medicine according to the B.C. Ministry of Health's Medical Services Plan (MSP) with a license status of private practice, temporary license, salaried, or post graduate.
- •iii. Hold a valid mailing address in B.C according to the College of Physicians and Surgeons of British Columbia's public physician information.
- •iv. Had >=100 prescriptions filled at a community pharmacy in 2020 according to PharmaNet claims.
- •v. Diagnosed >= 1 eligible patient with Uncomplicated Acute Cystitis (UAC) in 2019 or 2020 (for delay group: 2020 to 2021
排除标准
- •Non-physicians, or physicians who:
- •i. Were not registered with the College of Physicians and Surgeons of B.C. (CPSBC) ii. Were not classified as a General Practitioner or Family Practice - Emergency Medicine according to the B.C. Ministry of Health's Medical Services Plan (MSP) with a license status of private practice, temporary license, salaried, or post graduate.
- •iii. Had an invalid mailing address in B.C according to the College of Physicians and Surgeons of British Columbia's public physician information.
- •iv. Had <=100 prescriptions filled at a community pharmacy in 2020 according to PharmaNet claims.
- •v. Diagnosed <= 1 eligible patient with Uncomplicated Acute Cystitis (UAC) in 2019 or 2020 (for delay group: 2020 to 2021
结局指标
主要结局
Monthly prescribing of Nitrofurantoin
时间窗: The study period for the primary analysis is the 185 day period after the early intervention, which is from September 24, 2021 to March 28, 2022..
The primary outcome is the proportion of uncomplicated acute cystitis episodes treated with nitrofurantoin.
次要结局
- Monthly prescribing of ciprofloxacin, trimethoprim-sulfamethoxazole (TMP-SMX), and other antibiotics.(The study period for the primary analysis is the 185 day period after the early intervention, which is from September 24, 2021 to March 28, 2022.)
研究者
Colin Dormuth
Associate Professor
University of British Columbia